(Bloomberg) — Tilray Inc. shares tumbled as much as 13% in post-market trading after the cannabis company reported a wider-than-expected Ebitda loss and revenue that missed the lowest analyst estimate.Key InsightsTilray’s fourth-quarter revenue of $46.9 million was below the consensus estimate of $55.4 million and missed even the lowest analyst estimate of $53 million. It sold $17 million worth of recreational cannabis in the period, up 7.4% from the prior quarterIts adjusted Ebitda loss of $35.3 million also missed the consensus expectation of $21.8 million and was wider than the biggest estimated loss of $29.3 millionTilray announced that it closed …read more
Source:: Yahoo Finance
